Rehydratable pharmaceutical product

US9107833B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9107833-B2
Application numberUS-30504807-A
CountryUS
Kind codeB2
Filing dateJun 22, 2007
Priority dateJun 22, 2006
Publication dateAug 18, 2015
Grant dateAug 18, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A pharmaceutical product comprising lyophilized polymer matrix including a biologically active compound, of particular utility for embolization, having improved rehydration properties is packaged in an airtight package under vacuum.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of preparing a pharmaceutical suspension for administration to an animal comprising the steps: i) providing particles of polymer matrix swollen with water and having absorbed therein a non-volatile biologically active compound wherein the polymer is a water-insoluble water-swellable pharmaceutically acceptable polymer; ii) cooling the swollen particles from step i) in a freezing step to a temperature below the freezing point for water whereb…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9107833B2 cover?
A pharmaceutical product comprising lyophilized polymer matrix including a biologically active compound, of particular utility for embolization, having improved rehydration properties is packaged in an airtight package under vacuum.
Who is the assignee on this patent?
Willis Sean, Palmer Rosemary, Biocompatibles Uk Ltd
What technology area does this patent fall under?
Primary CPC classification A61K9/19. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).